Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | ALVOTECH | 4 | 11 | 0,00 % | |
 | FESTI | - | 2 | - | |
| EIMSKIP | - | 1 | - | |
| ARION BANK | - | - | -1,57 % | ||
| ICELANDAIR GROUP HF | - | - | - | |
| MAREL HF | - | - | - | |
| HAGAR | - | - | - | |
| VATRYGGINGAFELAG ISLANDS | - | - | - | |
| BRIM | - | - | - | |
| SJOVA | - | - | - |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Alvotech moves to bring its Humira biosimilar to US market | 2 | Pharmaceutical Technology | ||
| Fr | Alvotech deal could heighten biosimilar pressure on Humira | 2 | BioPharma Dive | ||
| Fr | Alvotech, Teva signs deal to expand access for Humira biosimilar in U.S. | 17 | Seeking Alpha | ||
| Fr | Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira (adalimumab) | 125 | GlobeNewswire (Europe) | Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar... ► Artikel lesen | |
| Mi | Stelara biosimilar from Alvotech, Teva approved by FDA | 7 | BioPharma Dive | ||
| Mi | Eimskipafelag Islands hf.: Updated Financial Calendar | 2 | GlobeNewswire (USA) | ||
| Mi | Alvotech and Teva gain FDA approval of Selarsdi for psoriasis | 13 | Pharmaceutical Technology | ||
| Mi | Alvotech And Teva: FDA Approves Selarsdi Injection For Psoriasis And Psoriatic Arthritis | 32 | RTTNews | ||
| Mi | Alvotech - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mi | FDA approves Alvotech biosimilar of J&J top-selling drug Stelara | 123 | Seeking Alpha | ||
| Mi | Teva, Alvotech rise as FDA approves Stelara biosimilar | 124 | Reuters | ||
| Di | Teva Pharmaceutical Industries Limited: Alvotech and Teva Announce U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara (ustekinumab) | 459 | Business Wire | SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva SELARSDI is expected to be... ► Artikel lesen | |
| Di | Festi hf.: Publication of Q1 2024 results on 23 April 2024 and investor meeting on 24 April | 218 | GlobeNewswire (USA) | ||
| Di | Amaroq Minerals: Director/PDMR Shareholding | 291 | GlobeNewswire (USA) | ||
| Mo | Festi hf.: Festi hf: Festi acquisition of all shares in Lyfja hf. - Conciliation talks begin with the Icelandic Competition Authority. | 831 | GlobeNewswire (Europe) | The Icelandic Competition Authority has agreed to Festi's request to start conciliation talks on possible remedies associated with Festi's acquisition of all shares in Lyfja hf. The conciliation talks... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
